You have 9 free searches left this month | for more free features.

Polycythemia Vera

Showing 51 - 75 of 416

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

Recruiting
  • Myeloproliferative Neoplasm
  • +5 more
  • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
  • Aspirin 81 mg
  • Ottawa, Ontario, Canada
    The Ottawa Hospital
Apr 19, 2022

Myelofibrosis Trial in Worldwide (PXS-5505)

Recruiting
  • Myelofibrosis
  • Birmingham, Alabama
  • +19 more
Nov 28, 2022

Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

Active, not recruiting
  • Myelofibrosis
  • +2 more
  • New Orleans, Louisiana
  • +20 more
Aug 25, 2022

A Prospective, Non-interventional Study of JAKAVI® Treatment in

Active, not recruiting
  • Polycythemia Vera
  • Jakavi
  • Reutlingen, Baden Wuerttemberg, Germany
  • +98 more
May 16, 2023

A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
Sep 6, 2021

Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

Recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablet
  • Canton, Ohio
    Site 01
Aug 18, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022

Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

Active, not recruiting
  • Polycythemia Vera
  • San Giovanni Rotondo, (FG) Puglia, Italy
  • +22 more
Jan 10, 2023

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Farmington Hills, Michigan
  • +1 more
Jun 5, 2021

Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • +3 more
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Jun 11, 2021

Essential Thrombocythemia, Polycythemia Vera Trial in Boston (Ruxolitinib)

Not yet recruiting
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Boston, Massachusetts
  • +2 more
Nov 24, 2020

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)

Completed
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Phoenix, Arizona
  • +12 more
Jan 12, 2021

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

Polycythemia Vera Trial in Worldwide (Best Available Therapy, Ruxolitinib)

Completed
  • Polycythemia Vera
  • Herston, Queensland, Australia
  • +47 more
Jun 29, 2021

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023